The aScope gastro large and Ambu aBox 2 expand the company’s gastroenterology (GI) offerings in Europe. It designed and tested the solution in close collaboration with leading GI experts. Ambu targets an expansion of more than 1.5 million annual procedures with the system.
According to a news release, the aScope gastro large and aBox 2 mark the world’s first gastroscope with a 4.2 mm working channel. That enables a powerful suction performance form the therapeutic gastroscope while providing maneuverability and precision. The company says this facilitates access to difficult-to-reach anatomical areas.
aScope gastro large delivers significantly higher suction performance compared to the latest 3.7 mm gastroscope on the market, Ambu said. It achieves this both with and without tools. The system also offers a valuable tool during upper GI procedures in the ICU and endoscopy unit. It helps in bleed management, necrosectomy and stent placement procedures, the company said.
The system features bioplastic materials, with its scope handle’s material derived from second-generation feedstock. Using recycled food waste ensures a notably lower carbon footprint, Ambu said.
CEO Britt Meelby Jensen says the launch marks the first step in the company’s commitment to sustainable endoscopy. It plans to pave the way for the use of bioplastics in all of its future endoscope handles.
“As a single-use endoscopy company, we believe that applying sustainable practices is both an obligation and an opportunity to lead by example,” said Meelby Jensen. “Being the first company in the world to bring an endoscope made with bioplastics to customers is not only a milestone for Ambu – it is a significant step forward within the industry, on the road to positive change.”
